Skip to main content
Caplight Logo









Synapse Medicine

Synapse Medicine

Private
BordeauxHealthcare & Life Scienceshttps://www.synapse-medicine.com/

Last Round

Series B

Mar 1, 2022

Total Funding Raised

$38.83M

Company Overview

Synapse Medicine is a health tech company that provides a Medication Intelligence SaaS platform for healthcare professionals to ensure proper drug use and prevent medication errors.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Vertical SaaS, Healthcare Analytics, Compliance

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS, Government Contracts, Freemium

AI Layer

Application

Keywords

medication reconciliationmedrec softwaremedication intelligenceclinical decision supportCDS softwaredrug information APIclinical AImedication error preventionpatient safety softwareEHR integrationdrug databasepharmacovigilance automationPV automationMedDRA coding

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Synapse Medicine Comparables

Compare Synapse Medicine with similar companies based on industry and business-model similarity.

Synapse Medicine comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Posos
85%
MDI Health
77%
FeelBetter
76%

Synapse Medicine Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BMar 1, 2022
Series AJul 6, 2020
SeedMar 19, 2019

Key People

Founding team and executive leadership

Clement Goehrs

Co-Founder & CEO

Founding Team

Clémence Bonnier

Chief Financial Officer

Executive Team

Synapse Medicine Investors

Notable investors and investment history

Synapse Medicine investors
InvestorRounds
Korelya CapitalSeries B
BNP Paribas DéveloppementSeries B
XAngeSeries A, Series B, Seed
BpifranceSeries A
BNP ParibasSeries A
MACSFSeries B, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 20, 2026

    Monthly visitors increased 32% MoM.

  • Nov 10, 2025

    Monthly visitors increased 76% MoM.

Synapse Medicine Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Synapse Medicine Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Synapse Medicine's valuation, stock price, and market status.

Firmographic Details

HeadquartersBordeaux
Employee Range85
Year Founded2017
Last FundingMar 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?